| Completed | First-in-Human Study of IMGC936 in Participants With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2020-10-29 |
| Completed | A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Pe Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer | Phase 3 | 2020-07-23 |
| Completed | Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubic Epithelial Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer | Phase 1 / Phase 2 | 2016-03-02 |
| Completed | A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor ( Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer | Phase 3 | 2016-03-02 |
| Completed | Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 1 | 2016-03-01 |
| Terminated | A Phase 1 Study of IMGN289 in Adult Patients With EGFR-positive Solid Tumors EGFR Positive Solid Tumors | Phase 1 | 2013-10-01 |
| Completed | First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuxim Tumors | Phase 1 | 2012-06-28 |
| Completed | IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukem Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia | Phase 1 | 2012-01-01 |
| Terminated | A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer Small Cell Lung Cancer | Phase 1 / Phase 2 | 2010-11-01 |
| Completed | IMGN901 in Combination With Lenalidomide and Dexamethasone Multiple Myeloma | Phase 1 | 2009-12-01 |
| Completed | A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors Solid Tumor | Phase 1 | 2008-06-01 |
| Withdrawn | huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas Stomach Neoplasms, Metastatic or Locally Advanced Gastric Cancer, Metastatic or Local Advanced GE Junction Cancer | Phase 2 | 2007-05-01 |
| Completed | BB-10901 in Treating Patients With Relapsed and/or Refractory Multiple Myeloma Multiple Myeloma | Phase 1 | 2005-04-01 |
| Completed | Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors Non-colorectal Cancer, Pancreatic Cancer | Phase 1 | 2005-02-01 |
| Completed | Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer Small Cell Lung Cancer | Phase 1 / Phase 2 | 2003-04-01 |
| Completed | BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors Ovarian Cancer, Merkel Cell Carcinoma, SCLC | Phase 1 | 2002-03-01 |